In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.
A newly issued report by the European Medicines Agency details an increase in inspections at active pharmaceutical ingredient (API) facilities as part of greater cooperation between European, US, and Australian regulatory authorities and the World...
Which drugs entering the market in 2018 are poised as blockbusters? DCAT Value Chain Insights examines the contenders launching this year.
A recent analysis by Clarivate Analytics points to 12 drugs entering the market this year that are expected...
The USP, a standard-setting organization, has stated that that it will not develop a new monograph for a biologic unless there is stakeholder consensus supporting its creation, including support from the FDA.
In making that decision, the USP...
From the use of real-world evidence to support the regulation of medicine to the continued rise of niche therapeutics, to increased use of mobile health and telehealth, what are the harbingers for healthcare transformation arising in 2018?
A new...
What have been the key developments from contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and other suppliers and companies supporting pharmaceutical /biopharmaceutical development and...
Challenged by reduced R&D productivity among large pharmaceutical companies and pricing pressures, slower growth is projected for the pharmaceutical industry in developed countries as growth in emerging markets moderates. So what is on the...
At the DCAT Member Company Announcement Forum, held during DCAT Week, senior executives from member companies of the Drug, Chemical & Associated Technologies Association (DCAT) provided the latest major news from their companies impacting the...
What does it take to drive innovation to improve business outcomes? Partnership strategies are key, according to a recent PwC study, a subject that will be explored at DCAT Week '18.
The DCAT education program, Innovation in Sourcing and...
How did the pharmaceutical industry perform in 2017, and what is the outlook for 2018 and beyond? Key for the industry is the performance of the US market, the largest national market in the global pharmaceutical industry, but what other factors...
An effective supply strategy is crucial for pharmaceutical companies, so what are the challenges that companies face? Managing risk, addressing shifts in product mix, and increasingly complex supply chains are some of the challenges.
The DCAT Week...
